Showing results (191-200 of 205) with videos related to
Sort By:
Pageof 21
Antioxidants & Redox Signaling|November 21, 2013
Targeting chelatable iron as a therapeutic modality in Parkinson's diseaseDavid Devos, Caroline Moreau, Jean Christophe Devedjian, et al.Journal of Parkinson'S Disease|May 23, 2022
Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical ModificationsQuentin Devignes, Sami Daoudi, Romain Viard, et al.Brain : a Journal of Neurology|September 26, 2013
Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcificationGaël Nicolas, Cyril Pottier, Camille Charbonnier, et al.NPJ Parkinson'S Disease|August 2, 2025
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysisAymeric Lanore, Christelle Tesson, Aymeric Basset, et al.Journal of Neurology|August 30, 2023
Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric studyAna Marques, Elise Macias, Bruno Pereira, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.Neuroimage. Clinical|October 24, 2022
Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's diseaseLaila Khedher, Jean-Marie Bonny, Ana Marques, et al.The Lancet. Neurology|June 5, 2012
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trialCaroline Moreau, Arnaud Delval, Luc Defebvre, et al.CNS Drugs|May 25, 2025
Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK CohortAymeric Lanore, Edouard Januel, Nathalie Bertille, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 17, 2018
Suggestive association between OPRM1 and impulse control disorders in Parkinson's diseaseFlorence Cormier-Dequaire, Samir Bekadar, Mathieu Anheim, et al.Pageof 21